Perioperative treatment with bactericidal/permeability-increasing protein (rBPI21) in major liver surgery: A concise summary

Annals of the Academy of Medicine Singapore

Volumn 30, Issue 3, 2001, Pages 226-233

  Wiezer, M J ^b   Boelens, P G ^b   Vuylsteke, R J C L M ^b   Nijveldt, R J ^b   Meijer, C ^b   Cuesta, M A ^a   Meijer, S ^a   Van Leeuwen, Paul A M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Amino acids; Clinical outcome; Coagulation and fybrinolysis; Endotoxin; Infections; Neutrophil function

Indexed keywords

AMINO ACID; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; ENDOTOXIN;

BACTERICIDAL ACTIVITY; BLOOD CLOTTING; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG PENETRATION; DRUG SAFETY; FIBRINOLYSIS; HUMAN; LEUKOCYTE ACTIVATION; LIVER RESECTION; LIVER SURGERY; MORBIDITY; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; TREATMENT OUTCOME;

EID: 0034866336     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (82)

1. Higginson J. Geographical pathology of primary liver cancer. Cancer Res 1963; 23:1624-33.
2. Pickren J W, Tsukada Y, Lane W W. Liver metastases: analysis of autopsy data. In: Weiss L, Gilbert HA, editors. Liver Metastases. Boston: Hall Medical Publishers, 1982:2-18.
3. Silverberg E, Boring C C, Squires T S. Cancer statistics, 1990. CA Cancer J Clin 1990; 40:318-9.
4. Butler J, Attiyeh F F, Daly J M. Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet 1986; 162:109-13.
5. De Brauw L M, De Vede C J H. Bouwhuis-Hoogerwerf M L. Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases. J Surg Oncol 1987; 34:81-6.
6. Cole D J, Ferguson C M. Complications of hepatic resection for colorectal carcinoma metastasis. Am Surg 1992; 58:88-91.
7. Finch M D, Crosbie J L, Currie E, Garden O J. An 8-year experience of hepatic resection: indications and outcome. Br J Surg 1998; 85:315-9.
8. Nagasue N, Kohno H, Chang Y C, Taniura Y, Yamanoi A, Uchida M, et al. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 1993; 4:375-84.
9. Oldenburg H S A, Boelens P G, Pruitt J, Wesdorp R I C, Rauwerda J, Meyer S, et al. Aortic aneurysm repair is associated with a lower inflammatory response compared to surgery for inflammatory bowel disease [thesis]. Amsterdam: HSA Oldenburg, 2000.
10. Kloosterman T, von Blomberg M E, Borgstein P, Cuesta M A, Scheper R J, Meijer S. Unimpaired immune function after laparoscopic cholecystectomy. Surgery 1999; 115:424-8.
11. Sietses C, Wiezer M J, Eijsbouts Q A J, Beelen R H J, van Leeuwen P A M, von Blomberg B M E, et al. A prospective randomised study of the immune response after laparoscopic and conventional Nissen fundoplication. Surgery 1999; 125:5-9.
12. Sietses C, Wiezer M J, Eijsbouts Q A J, van Leeuwen P A M, Beelen R HJ, Meijer S, et al. The influence of laparoscopic surgery on postoperative polymorphoneuclear leukocyte function. Surg Endosc 2000; 14:812-6.
13. Houdijk A P J, Rijnsburger E R, Jansen J, Wesdorp R I C, Weiss J K, McCamish M A, et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 1998; 352:772-6.
14. Mels A K, Statius Muller M G, van Leeuwen P A M, von Blomberg B M E, Scheper R J, Cuesta M A, et al. Immune-stimulating effects of low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients operated on for primary colorectal carcinoma. Br J Surg 2001; 88: 539-44.
15. Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozzetti F, et al. Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg 1995; 82:377-81.
16. Wilder Baker J, Deitch E A, Berg R D, Specian R D. Hemorrhagic shock induces bacterial translocation from the gut. J Trauma 1988; 28: 896-905.
17. Nolan J P. Endotoxin, RES function and liver injury. Hepatology 1981; 1:458-65.
18. Gonella P A, Helton W S, Robinson M, Wilmore D W. O-side chain of Escherichia coli endotoxin 0111:B4 is transported across the intestinal epithelium in the rat: evidence for increased transport during total parenteral nutrition. Eur J Cell Biol 1992; 59:224-7.
19. Jacob A I, Goldberg P K, Bloom N, Degenshein G A, Kozinn P J. Endotoxin and bacteria in portal blood. Gastroenterology 1977; 72: 1268-70.
20. Meijer C, Statius Muller M G, van Leeuwen P A M. The liver in the induction and regulation of the acute stress response. In: Revhaug A, editor. Acute Catabolic State. Update in Intensive Care and Emergency Medicine. Berlin: Springer-Verlag, 1996:129-40.
21. Boermeester M A, Straatsburg I H, Houdijk A P J, Meijer C, Frederiks W M, Wesdorp R I C, et al. Endotoxin and interleukin-1 related hepatic inflammatory response promotes liver failure after partial hepatectomy. Hepatology 1995; 22:1499-506.
22. Wortel C H, van Deventer S J H, Aarden L A, Lygidakis N J, Büller H R, Hoek F J, et al. Interleukin-6 mediates host defence responses by abdominal surgery. Surgery 1993; 114:564-70.
23. Wright S D, Tobias P S, Ulevitch R J, Ramos R A. Lipopolysacharide binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med 1989; 170:1231-41.
24. Morrison D C, Ryan J L. Endotoxins and disease mechanisms. Annu Rev Med 1987; 38:417-32.
25. Lowry S F. Tumor necrosis factor and other cytokines as mediators of clinical sepsis. In: Faist E, Meakins J L, Schildberg F W, editors. Host Defence Dysfunction in Trauma, Shock, and Sepsis. Berlin: Springer-Verlag, 1993:253-61.
26. Michie H R, Manogue K R, Spriggs D R, Revhaug A, O'Dwyer S, Dinarello C A, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318:1481-6.
27. Cannon J G, Tompkins R G, Gelfand J A, Michie H R, Stanford G G, van der Meer J W M. et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990; 161:79-84.
28. Fong Y, Moldawer L L, Marano M, Wei H, Tatter S B, Clarick R H, et al. Endotoxemia elicits increased circulating V2-IFN/Il-6 in man. J Immunol 1989; 142:2321-4.
29. Van Deventer S J, Hart M, van der Poll T, Hack C E, Aarden L A. Endotoxin and tumor necrosis factor alpha-induced interleukin-8 release in humans. J Infect Dis 1993; 167:461-4.
30. Van Deventer S H J, Buller H R, ten Cate J W, Aarden L A, Hack C E, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 1990; 76:2520-7.
31. Luster M I, Germolec D R, Yoshida T, Kayama F, Thompson M. Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology 1994; 19:480-8.
32. Callery M P, Kamei T, Flye M W. Endotoxin stimulates interleukin-6 production by human kupffer cells. Circ Shock 1992; 37:185-8.
33. Salkowski C A, Neta R, Wynn T A, Strassmann G, Van Rooijen N, Vogel S N. Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotection. J Immunol 1995; 155:3168-79.
34. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990; 192:245-61.
35. Akerman A, Cote P, Yang Q S, McClain C, Nelson S, Bagby G J, et al. Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992; 263:G579-G585.
36. Fausto N, Laird A D, Webber E M. Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995; 9:1527-36.
37. Maher J J. Cell-specific expression of hepatocyte growth factor in liver. J Clin Invest 1993; 91:2244-52.
38. Michalopoulos G K. Liver regeneration: molecular mechanisms of growth control. FASEB J 1990; 4:176-87.
39. Cressman D E, Greenbaum L E, DeAngelis R A, Ciliberto G, Furth E E, Poli V, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274:1379-83.
40. Ohira H, Miyata M, Kuroda M, Takagi T, Tojo J, Ochiai H, et al. Interleukin-6 induces proliferation of rat hepatocytes in vivo. J Hepatol 1996; 25:941-7.
41. 2MDP liposomes surpresses liver regeneration after partial hepatectomy. Liver 2000; 20:66-77.
42. Tiegs G, Wolter M, Wendel A. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 1989; 38:627-31.
43. Czaja M J, Xu J, Alt E. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 1995; 108:1849-54.
44. Beutler B, Milsark I W, Cerami A C. Passive immunisation against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229:869-71.
45. Bauer M, Marzi I, Thuma B, Bach F, Bühren V, Larsen R. Dose-related pattern of sinusoidal leukocyte adhesion in sublobular regions of the liver after systemic endotoxin challenge in the rat. Shock 1994; 2:135-40.
46. Suzuki S, Nakamura S, Serizawa A, Sakaguchi T, Konno H, Muro H, et al. Role of Kupffer cells and spleen in modulationof endotoxin-induced liver injury after partial hepatectomy. Hepatology 1996; 24:219-25.
47. Ho J S, Buchweitz J P, Roth R A, Ganey P E. Identification of factors from rat neutrophils responsible for cytotoxicity to isolated hepatocytes. J Leukoc Biol 1996; 59:716-24.
48. Schmid-Schonbein G W. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed Proc 1987; 46:2397-401.
49. Pagetti R S, Moore F A, Moore E E, Bensard D D, Anderson B O, Banerjee A. Liver injury is a reversible neutrophil-mediated event following gut ischemia. Arch Surg 1992; 127:175-9.
50. Moshida S, Ogata I, Hirata K, Ohta Y, Yamada S, Fujiwara K. Provocation of massive hepatic necrosis by endotoxin after partial hepatectomy in rats. Gastroenterology 1990; 99:771-7.
51. van Leeuwen P A M, Hong R W, Rounds J D, Rodrick M, Wilmore D W. Hepatic failure and coma after liver resection is reversed by manipulation of the gut contents: the role of endotoxin. Surgery 1991; 110:169-75.
52. Nolan J P. The role of endotoxin in liver injury. Gastroenterology 1975; 8:1346-56.
53. van Leeuwen P A M, Boermeester M A, Houdijk A P J, Meyer S, Wesdorp R I C, Rodrick M L. et al. Pretreatment with enteral cholestyramine prevents surpression of the cellular immune system after partial hepatectomy. Ann Surg 1995; 221:282-90.
54. Boermeester M A, Houdijk A P J, Meijer S, Cuesta M A, Appelmelk B J, Wesdorp R I C, et al. Liver failure induces a systemic inflammatory response. Prevention by recombinant N-terminal bactericidal/ permeability-increasing protein. Am J Pathol 1995; 147:1428-40.
55. Weiss J, Elsbach P, Olsson I, Odeberg H. Purification and characterization of a potent bacterial and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem 1978; 253: 2664-72.
56. Elsbach P, Weiss J, Franson R, Beckerdite-Quagliata S, Schneider A, Harris L. Separation and purification of a potent bactericidal/ permeability-increasing protein and a closely associated phospholipase A, from rabbit polymorphonuclear leukocytes. J Biol Chem 1979; 254:11000-9.
57. Horwitz A H, Leigh S D, Abrahamson S, Gazzano-Santoro H, Liu P S, Williams R E, et al. Expression and characterization of cysteine-modified variants of an amino-terminal fragment of bactericidal/ permeability-increasing protein. Protein Expr Purif 1996; 8:28-40.
58. Bauer R J, Der K, Ottah-Ihejeto N, Barrientos J, Kung A H C. The role of liver and kidney on the pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability-increasing protein in rats. Pharm Res 1997; 14:224-9.
59. 21) after liver surgery in rats and humans. Shock 1998; 10:161-6.
60. 21) in the prevention of the inflammatory response after liver resection: results of the low dose phase. In: Faist E, editor. 4th International Congress on the Immune Consequences of Trauma, Shock and Sepsis. Mechanisms and Therapeutic Approaches. Bologna: Monduzzi Editore, 1997:769-73.
61. 21 in the prevention of complications after major liver resection: a randomized, double-blind, placebo-controlled, multicenter trial. Hepatology 1999; 30:684A.
62. Fischer J E, Funovics J M, Aguirre A, James J H, Keane J M, Wesdorp R I, et al. The role of plasma amino acids in hepatic encephalopathy. Surgery 1975; 78:276-90.
63. Fischer J E, Rosen H M, Ebeid A M, James J H, Keane J M, Soeters P B. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 1976; 80:77-91.
64. Mans A M, DeJoseph M R, Hawkins R A. Metabolic abnormalities and grade of encephalopathy in acute hepatic failure. J Neurochem 1994; 63:1829-38.
65. Rosen H M, Yoshimura N, Hodgman J M. Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 1977; 72:483-7.
66. Nijveldt R J. Wiezer M J, Meijer C, Gouma D J, Borel Rinkes I H M, Tilanus H W, et al. Major liver resection results in a changed plasma amino acid pattern as reflected by a decreased Fisher ratio which improves by administration of bactericidal/permeability increasing protein. Liver 2001; 21:56-63.
67. Tsuzuki T, Toyama K, Nakayasu K, Iida S, Ueda M, Toizumi A. Disseminated intravascular coagulation after hepatic resection. Surgery 1990; 107:172-6.
68. 23). Blood 1995; 85: 3437-43.
69. 21 and the role of decreased synthesis of regulating proteins by the liver. Shock 2001; 15:261-71.
70. Duignan J P, Collins P B, Johnson A H, Boucher-Hayes D. The association of impaired neutrophil chemotaxis with post-operative surgical sepsis. Br J Surg 1986; 73:238-40.
71. Buffone V, Meakins J L, Christou N V. Neutrophil function in surgical patients: relationship to adequate bacterial defences. Arch Surg 1984; 119:39-43.
72. Van Dijk W C, Verbrugh H A, van Rijswijk R E N, Vos A, Verhoef J. Neutrophil function, serum opsonic activity, and delayed hypersensiti vity in surgical patients. Surgery 1982; 92:21-9.
73. Wiezer M, Meijer C, Wallast-Groenewoud H, Tool A J, Prins H A, Houdijk A P J, et al. Impaired leukocyte phagocytosis in patients undergoing hemihepatectomy for liver metastases. J Liver Transpl Surg 1999; 5:238-45.
74. Utoh J, Yamamoto T, Utsunomiya T, Kambara T, Goto H, Miyauchi Y. Effects of surgery on neutrophil functions, superoxide and leukotriene production. Br J Surg 1988; 75:682-5.
75. Davies M, Sheppard K, Fletcher J. The effects of surgery on the activity of neutrophil granule proteins. Br J Haematol 1983; 53:5-13.
76. El-Maallem H, Fletcher J. Effects of surgery on neutrophil granulocyte function. Infect Immun 1981; 32:38-41.
77. Guthrie L A, McPhail L C, Henson P M, Johnston Jr R B. Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysacharide. J Exp Med 1984; 160:1656-71.
78. Böhmer R H, Trinkle L S, Staneck J L. Dose effects of LPS on neutrophils in a whole blood flow cytometric assay of phagocytosis and oxidative burst. Cytometry 1992; 13:525-31.
79. Bass D A, Olbrantz P, Szedja P, Seeds M C, McCal C E. Subpopulations of neutrophils with increased oxidative product formation in blood of patients with infection. J Immunol 1986; 136:860-6.
80. 21 preserves leukocyte functions after major liver resection. Ann Surg 2000; 232:208-15.
81. 21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. Lancet 2000; 356:961-7.
82. 21 acute hemorrhagic trauma study group. Bactericidal/ permeability-increasing protein (rBPI) in patients with hemorrhage due to trauma: results of a multicenter phase II trial. J Trauma 1999; 46: 667-76.